Wegovy

Amazon Pharmacy is expanding into the weight-loss drug market by offering Novo Nordisk’s oral Wegovy pill. This move increases patient access to the popular medication, previously dominated by injectables. Amazon aims to make treatment more accessible with pricing as low as $25 per month with insurance and $149 without. The integration with One Medical clinics further streamlines prescription fulfillment, highlighting Amazon’s growing presence in healthcare. This strategic expansion positions Amazon as a key player in reshaping weight management treatments.

Hims & Hers Health introduced a six-month Wegovy® subscription at $549/month, a 15% discount on average retail prices, to expand access to prescription weight-loss care. The limited-time offer via telehealth includes consultations, nutritional tools, and progress tracking, leveraging Novo Nordisk’s expanded production. CEO Andrew Dudum emphasized affordability in chronic care, while analysts note the model bridges payer-patient cost gaps. The initiative aligns with a 212% annual rise in metabolic health consultations, reflecting consumer demand for preventive solutions. Promotion runs through June 30, 2025, with eligibility criteria on the company’s platform. Hims & Hers continues offering compounded alternatives and behavioral programs in the $100 billion wellness sector.